| P50 | author | Cedric N Berger | Q57031313 |
| | Gad Frankel | Q63865535 |
| | Luis Ángel Fernández | Q42770872 |
| | Samuel J. Ellis | Q47097326 |
| | Stephanie Schüller | Q47097350 |
| P2093 | author name string | Simon Wemyss-Holden | |
| | Alistair D S Walsham | |
| | Massiel Cepeda-Molero | |
| P2860 | cites work | A bacterial effector targets host DH-PH domain RhoGEFs and antagonizes macrophage phagocytosis | Q24304013 |
| | Enteropathogenic escherichia coli infection in children | Q26830066 |
| | Bacterial type III secretion systems: specialized nanomachines for protein delivery into target cells | Q27028058 |
| | Structural insights into host GTPase isoform selection by a family of bacterial GEF mimics | Q27656575 |
| | Type Three Secretion System in Attaching and Effacing Pathogens | Q28074332 |
| | Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa. | Q30451109 |
| | The role of lymphostatin/EHEC factor for adherence-1 in the pathogenesis of gram negative infection | Q33398124 |
| | The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. | Q33582255 |
| | Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo | Q33716089 |
| | Functional analysis of lymphostatin homologues in enterohaemorrhagic Escherichia coli. | Q53626391 |
| | A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. | Q54574143 |
| | Intimin-mediated tissue specificity in enteropathogenic Escherichia coli interaction with human intestinal organ cultures | Q73670514 |
| | Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration | Q41506828 |
| | Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. | Q41823804 |
| | The type III secretion effector NleE inhibits NF-kappaB activation | Q41893338 |
| | EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation | Q42103443 |
| | Engineering the Controlled Assembly of Filamentous Injectisomes in E. coli K-12 for Protein Translocation into Mammalian Cells | Q42592138 |
| | Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells. | Q42617902 |
| | The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. | Q42677853 |
| | Efa-1/LifA mediates intestinal colonization of calves by enterohaemorrhagic Escherichia coli O26 : H- in a manner independent of glycosyltransferase and cysteine protease motifs or effects on type III secretion | Q43064185 |
| | Role of periplasmic chaperones and BamA (YaeT/Omp85) in folding and secretion of intimin from enteropathogenic Escherichia coli strains | Q43071863 |
| | Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli | Q44038146 |
| | Contribution of Efa1/LifA to the adherence of enteropathogenic Escherichia coli to epithelial cells | Q47931724 |
| | Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells | Q48042079 |
| | Role of intimin and bundle-forming pili in enteropathogenic Escherichia coli adhesion to pediatric intestinal tissue in vitro | Q33752405 |
| | Direct injection of functional single-domain antibodies from E. coli into human cells | Q33775617 |
| | Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure | Q33944789 |
| | A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation | Q34003951 |
| | Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements | Q34177961 |
| | The interplay between the Escherichia coli Rho guanine nucleotide exchange factor effectors and the mammalian RhoGEF inhibitor EspH | Q34247723 |
| | Actin pedestal formation by enterohemorrhagic Escherichia coli enhances bacterial host cell attachment and concomitant type III translocation | Q34298474 |
| | The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection | Q34596147 |
| | A mosaic pathogenicity island made up of the locus of enterocyte effacement and a pathogenicity island of Escherichia coli O157:H7 is frequently present in attaching and effacing E. coli | Q35012568 |
| | Metalloprotease NleC suppresses host NF-κB/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interaction | Q35163621 |
| | A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation | Q35228516 |
| | The Serine Protease EspC from Enteropathogenic Escherichia coli Regulates Pore Formation and Cytotoxicity Mediated by the Type III Secretion System. | Q35680038 |
| | Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens | Q36211798 |
| | NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation | Q36557738 |
| | Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter | Q37008377 |
| | Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal | Q37021415 |
| | Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. | Q37106331 |
| | The bacterial virulence factor lymphostatin compromises intestinal epithelial barrier function by modulating rho GTPases | Q37164543 |
| | Subcellular alterations that lead to diarrhea during bacterial pathogenesis | Q37280162 |
| | Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells | Q37507829 |
| | Bacterial interactions with the host epithelium. | Q37773685 |
| | Infection strategies of enteric pathogenic Escherichia coli | Q38007348 |
| | Intimate host attachment: enteropathogenic and enterohaemorrhagic Escherichia coli | Q38127457 |
| | The cell death response to enteropathogenic Escherichia coli infection | Q38255302 |
| | Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways | Q38318508 |
| | EspC, an Autotransporter Protein Secreted by Enteropathogenic Escherichia coli, Causes Apoptosis and Necrosis through Caspase and Calpain Activation, Including Direct Procaspase-3 Cleavage | Q38762934 |
| | Enterohemorrhagic Escherichia coli colonization of human colonic epithelium in vitro and ex vivo | Q38926009 |
| | EspC promotes epithelial cell detachment by enteropathogenic Escherichia coli via sequential cleavages of a cytoskeletal protein and then focal adhesion proteins | Q39014117 |
| | Markerless gene replacement in Escherichia coli stimulated by a double-strand break in the chromosome | Q39729563 |
| | Enteropathogenic Escherichia coli: identification of a gene cluster coding for bundle-forming pilus morphogenesis | Q39841227 |
| | The mechanisms used by enteropathogenic Escherichia coli to control filopodia dynamics | Q39910582 |
| | EspC translocation into epithelial cells by enteropathogenic Escherichia coli requires a concerted participation of type V and III secretion systems | Q39973164 |
| | Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli | Q40007146 |
| | Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models | Q40138256 |
| | Enterohaemorrhagic E. coli modulates an ARF6:Rab35 signaling axis to prevent recycling endosome maturation during infection | Q40645878 |
| | Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions | Q40997195 |
| | A Novel Mechanism for Protein Delivery by the Type 3 Secretion System for Extracellularly Secreted Proteins | Q41359807 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P921 | main subject | Escherichia coli | Q25419 |
| | enteropathogen | Q63500873 |
| P304 | page(s) | e1006706 | |
| P577 | publication date | 2017-10-30 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors | |
| P478 | volume | 13 | |